Lazurite is a pioneering biotechnology startup with a focus on revolutionizing surgical procedures through agile technologies. Their slogan "Agile technologies for optimal care" perfectly encapsulates their mission to enhance surgical processes. Since 2015, Lazurite has been disrupting the industry by introducing groundbreaking innovations such as the first wireless arthroscopic surgical camera system, ArthroFree. ArthroFree, their flagship product, has already made significant strides in the medical field, with widespread deployment across operating rooms in the United States. This innovative system has effectively resolved a persistent challenge faced by surgeons for over half a century - the issue of cumbersome camera cables. Not only does ArthroFree eliminate this longstanding obstacle, but it also simplifies the sterile field, streamlines setups and procedures, and eradicates the associated risks of contamination, drape fires, and patient burns. Furthermore, Lazurite received a significant boost through a Non-Equity Assistance investment from MedTech Innovator on 07 June 2022. This investment serves as a testament to the industry's confidence in Lazurite's transformative technology and its potential to reshape the future of surgical practices. With its innovative solutions and strong backing, Lazurite is well-positioned to continue its pioneering advancements in the biotechnology sector.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Non Equity Assistance | Unknown | 1 | 07 Jun 2022 | |
Venture Round | Unknown | 1 | 22 Feb 2022 | |
Debt Financing | $10.00M | 2 | AUA Private Equity Partners | 25 Jun 2021 |
Venture Round | Unknown | 1 | 06 Sep 2017 | |
Venture Round | $4.50M | - | 19 May 2017 |
No recent news or press coverage available for Lazurite.